Fluorine in PDB 5lay: Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G
Protein crystallography data
The structure of Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G, PDB code: 5lay
was solved by
D.Kessler,
A.Gollner,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
87.45 /
2.71
|
Space group
|
P 65 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
71.450,
71.450,
520.977,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
25.1 /
29.2
|
Other elements in 5lay:
The structure of Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G
(pdb code 5lay). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G, PDB code: 5lay:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 5lay
Go back to
Fluorine Binding Sites List in 5lay
Fluorine binding site 1 out
of 6 in the Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F205
b:7.8
occ:1.00
|
F38
|
A:6SS205
|
0.0
|
7.8
|
1.0
|
C37
|
A:6SS205
|
1.4
|
7.8
|
1.0
|
C2
|
A:6SS205
|
2.4
|
7.7
|
1.0
|
C6
|
A:6SS205
|
2.4
|
7.6
|
1.0
|
C7
|
A:6SS205
|
2.8
|
7.3
|
1.0
|
CL1
|
A:6SS205
|
2.9
|
8.1
|
1.0
|
C28
|
A:6SS205
|
3.0
|
7.3
|
1.0
|
C27
|
A:6SS205
|
3.2
|
7.2
|
1.0
|
CD1
|
A:ILE99
|
3.4
|
6.9
|
1.0
|
O
|
A:VAL93
|
3.6
|
8.1
|
1.0
|
C26
|
A:6SS205
|
3.6
|
7.2
|
1.0
|
C3
|
A:6SS205
|
3.6
|
7.4
|
1.0
|
C29
|
A:6SS205
|
3.6
|
7.1
|
1.0
|
C5
|
A:6SS205
|
3.7
|
7.9
|
1.0
|
CD2
|
A:HIS96
|
3.8
|
13.2
|
1.0
|
NE2
|
A:HIS96
|
3.8
|
13.7
|
1.0
|
C33
|
A:6SS205
|
3.9
|
7.1
|
1.0
|
C4
|
A:6SS205
|
4.1
|
7.6
|
1.0
|
C9
|
A:6SS205
|
4.3
|
7.3
|
1.0
|
C30
|
A:6SS205
|
4.3
|
7.1
|
1.0
|
C32
|
A:6SS205
|
4.4
|
7.0
|
1.0
|
CE1
|
A:HIS96
|
4.4
|
13.9
|
1.0
|
CD1
|
A:LEU54
|
4.4
|
6.5
|
1.0
|
CG
|
A:HIS96
|
4.5
|
13.2
|
1.0
|
C35
|
A:6SS205
|
4.5
|
7.1
|
1.0
|
C
|
A:VAL93
|
4.5
|
7.7
|
1.0
|
CG2
|
A:ILE99
|
4.5
|
6.9
|
1.0
|
N34
|
A:6SS205
|
4.6
|
7.2
|
1.0
|
N15
|
A:6SS205
|
4.6
|
7.1
|
1.0
|
N11
|
A:6SS205
|
4.6
|
7.4
|
1.0
|
CG1
|
A:ILE99
|
4.6
|
6.9
|
1.0
|
CA
|
A:VAL93
|
4.7
|
7.2
|
1.0
|
CB
|
A:VAL93
|
4.8
|
7.1
|
1.0
|
ND1
|
A:HIS96
|
4.8
|
13.6
|
1.0
|
CB
|
A:ILE99
|
4.8
|
6.9
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 5lay
Go back to
Fluorine Binding Sites List in 5lay
Fluorine binding site 2 out
of 6 in the Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F202
b:7.6
occ:1.00
|
F38
|
B:6SS202
|
0.0
|
7.6
|
1.0
|
C37
|
B:6SS202
|
1.4
|
7.5
|
1.0
|
C2
|
B:6SS202
|
2.3
|
7.7
|
1.0
|
C6
|
B:6SS202
|
2.4
|
6.9
|
1.0
|
C7
|
B:6SS202
|
2.8
|
6.4
|
1.0
|
CL1
|
B:6SS202
|
2.9
|
8.9
|
1.0
|
C28
|
B:6SS202
|
3.0
|
6.7
|
1.0
|
C27
|
B:6SS202
|
3.2
|
6.7
|
1.0
|
CD1
|
B:ILE99
|
3.3
|
4.4
|
1.0
|
C26
|
B:6SS202
|
3.6
|
6.3
|
1.0
|
C3
|
B:6SS202
|
3.6
|
7.3
|
1.0
|
CD2
|
B:HIS96
|
3.6
|
10.1
|
1.0
|
C5
|
B:6SS202
|
3.7
|
7.0
|
1.0
|
O
|
B:VAL93
|
3.7
|
3.8
|
1.0
|
C29
|
B:6SS202
|
3.7
|
6.7
|
1.0
|
C33
|
B:6SS202
|
4.0
|
6.9
|
1.0
|
C4
|
B:6SS202
|
4.1
|
7.1
|
1.0
|
C9
|
B:6SS202
|
4.3
|
5.9
|
1.0
|
NE2
|
B:HIS96
|
4.3
|
10.2
|
1.0
|
CD1
|
B:LEU54
|
4.4
|
5.5
|
1.0
|
C30
|
B:6SS202
|
4.5
|
7.0
|
1.0
|
CG2
|
B:ILE99
|
4.5
|
4.3
|
1.0
|
N11
|
B:6SS202
|
4.5
|
5.6
|
1.0
|
CG1
|
B:ILE99
|
4.5
|
4.3
|
1.0
|
C35
|
B:6SS202
|
4.6
|
6.3
|
1.0
|
N15
|
B:6SS202
|
4.6
|
6.0
|
1.0
|
C32
|
B:6SS202
|
4.6
|
6.9
|
1.0
|
C
|
B:VAL93
|
4.6
|
3.5
|
1.0
|
CB
|
B:ILE99
|
4.7
|
4.5
|
1.0
|
N34
|
B:6SS202
|
4.7
|
6.6
|
1.0
|
CG
|
B:HIS96
|
4.8
|
9.7
|
1.0
|
CA
|
B:VAL93
|
4.9
|
3.3
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 5lay
Go back to
Fluorine Binding Sites List in 5lay
Fluorine binding site 3 out
of 6 in the Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F202
b:8.0
occ:1.00
|
F38
|
C:6SS202
|
0.0
|
8.0
|
1.0
|
C37
|
C:6SS202
|
1.4
|
8.2
|
1.0
|
C2
|
C:6SS202
|
2.3
|
8.2
|
1.0
|
C6
|
C:6SS202
|
2.4
|
7.9
|
1.0
|
C7
|
C:6SS202
|
2.8
|
7.6
|
1.0
|
CL1
|
C:6SS202
|
2.8
|
8.7
|
1.0
|
C28
|
C:6SS202
|
3.0
|
6.8
|
1.0
|
C27
|
C:6SS202
|
3.2
|
7.0
|
1.0
|
CD1
|
C:ILE99
|
3.3
|
5.9
|
1.0
|
O
|
C:VAL93
|
3.5
|
6.0
|
1.0
|
C26
|
C:6SS202
|
3.6
|
7.3
|
1.0
|
C3
|
C:6SS202
|
3.6
|
8.2
|
1.0
|
C5
|
C:6SS202
|
3.7
|
8.1
|
1.0
|
C29
|
C:6SS202
|
3.7
|
6.6
|
1.0
|
C33
|
C:6SS202
|
4.0
|
7.0
|
1.0
|
ND1
|
C:HIS96
|
4.1
|
9.3
|
1.0
|
C4
|
C:6SS202
|
4.1
|
8.1
|
1.0
|
CE1
|
C:HIS96
|
4.1
|
9.4
|
1.0
|
O
|
C:HOH307
|
4.2
|
30.9
|
1.0
|
C9
|
C:6SS202
|
4.3
|
7.7
|
1.0
|
C30
|
C:6SS202
|
4.4
|
6.6
|
1.0
|
C32
|
C:6SS202
|
4.5
|
6.8
|
1.0
|
C
|
C:VAL93
|
4.5
|
6.0
|
1.0
|
CD1
|
C:LEU54
|
4.5
|
5.4
|
1.0
|
C35
|
C:6SS202
|
4.5
|
7.2
|
1.0
|
CG2
|
C:ILE99
|
4.5
|
5.9
|
1.0
|
N11
|
C:6SS202
|
4.6
|
8.3
|
1.0
|
CG1
|
C:ILE99
|
4.6
|
5.9
|
1.0
|
N15
|
C:6SS202
|
4.6
|
7.6
|
1.0
|
N34
|
C:6SS202
|
4.6
|
7.0
|
1.0
|
CA
|
C:VAL93
|
4.7
|
5.8
|
1.0
|
CB
|
C:VAL93
|
4.8
|
5.5
|
1.0
|
CB
|
C:ILE99
|
4.8
|
5.9
|
1.0
|
CG
|
C:HIS96
|
4.9
|
8.7
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 5lay
Go back to
Fluorine Binding Sites List in 5lay
Fluorine binding site 4 out
of 6 in the Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F202
b:6.0
occ:1.00
|
F38
|
D:6SS202
|
0.0
|
6.0
|
1.0
|
C37
|
D:6SS202
|
1.4
|
6.0
|
1.0
|
C2
|
D:6SS202
|
2.4
|
6.3
|
1.0
|
C6
|
D:6SS202
|
2.4
|
5.6
|
1.0
|
C7
|
D:6SS202
|
2.9
|
5.0
|
1.0
|
CL1
|
D:6SS202
|
2.9
|
7.0
|
1.0
|
C28
|
D:6SS202
|
3.1
|
5.8
|
1.0
|
C27
|
D:6SS202
|
3.2
|
5.4
|
1.0
|
CD1
|
D:ILE99
|
3.3
|
7.7
|
1.0
|
C26
|
D:6SS202
|
3.6
|
5.0
|
1.0
|
C3
|
D:6SS202
|
3.6
|
6.2
|
1.0
|
C5
|
D:6SS202
|
3.7
|
5.9
|
1.0
|
O
|
D:VAL93
|
3.7
|
6.6
|
1.0
|
C29
|
D:6SS202
|
3.7
|
5.9
|
1.0
|
C33
|
D:6SS202
|
3.9
|
5.5
|
1.0
|
NE2
|
D:HIS96
|
4.0
|
13.1
|
1.0
|
C4
|
D:6SS202
|
4.1
|
6.1
|
1.0
|
CD2
|
D:HIS96
|
4.2
|
13.0
|
1.0
|
C9
|
D:6SS202
|
4.3
|
4.7
|
1.0
|
CE1
|
D:HIS96
|
4.3
|
13.4
|
1.0
|
C30
|
D:6SS202
|
4.3
|
6.1
|
1.0
|
C32
|
D:6SS202
|
4.5
|
5.8
|
1.0
|
CG1
|
D:ILE99
|
4.5
|
7.8
|
1.0
|
CG2
|
D:ILE99
|
4.5
|
7.6
|
1.0
|
CG
|
D:HIS96
|
4.5
|
12.8
|
1.0
|
C35
|
D:6SS202
|
4.6
|
5.2
|
1.0
|
ND1
|
D:HIS96
|
4.6
|
13.8
|
1.0
|
N34
|
D:6SS202
|
4.6
|
5.4
|
1.0
|
C
|
D:VAL93
|
4.6
|
6.0
|
1.0
|
N11
|
D:6SS202
|
4.6
|
4.5
|
1.0
|
N15
|
D:6SS202
|
4.7
|
4.5
|
1.0
|
CB
|
D:ILE99
|
4.8
|
7.9
|
1.0
|
CA
|
D:VAL93
|
4.8
|
5.7
|
1.0
|
CB
|
D:VAL93
|
4.9
|
5.6
|
1.0
|
CD2
|
D:LEU54
|
4.9
|
3.7
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 5lay
Go back to
Fluorine Binding Sites List in 5lay
Fluorine binding site 5 out
of 6 in the Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:F203
b:5.0
occ:1.00
|
F38
|
E:6SS203
|
0.0
|
5.0
|
1.0
|
C37
|
E:6SS203
|
1.4
|
5.1
|
1.0
|
C2
|
E:6SS203
|
2.4
|
5.2
|
1.0
|
C6
|
E:6SS203
|
2.4
|
4.9
|
1.0
|
C7
|
E:6SS203
|
2.8
|
4.9
|
1.0
|
CL1
|
E:6SS203
|
2.9
|
5.5
|
1.0
|
C28
|
E:6SS203
|
3.1
|
4.2
|
1.0
|
CD1
|
E:ILE99
|
3.2
|
6.6
|
1.0
|
C27
|
E:6SS203
|
3.3
|
4.3
|
1.0
|
ND1
|
E:HIS96
|
3.6
|
9.5
|
1.0
|
C3
|
E:6SS203
|
3.6
|
5.2
|
1.0
|
C5
|
E:6SS203
|
3.7
|
4.9
|
1.0
|
C26
|
E:6SS203
|
3.7
|
4.5
|
1.0
|
O
|
E:VAL93
|
3.7
|
7.0
|
1.0
|
C29
|
E:6SS203
|
3.8
|
4.0
|
1.0
|
CE1
|
E:HIS96
|
3.9
|
9.8
|
1.0
|
C33
|
E:6SS203
|
4.1
|
4.2
|
1.0
|
C4
|
E:6SS203
|
4.1
|
5.0
|
1.0
|
C9
|
E:6SS203
|
4.2
|
5.2
|
1.0
|
N11
|
E:6SS203
|
4.4
|
5.3
|
1.0
|
CG2
|
E:ILE99
|
4.4
|
6.8
|
1.0
|
CG1
|
E:ILE99
|
4.5
|
6.7
|
1.0
|
CD1
|
E:LEU54
|
4.5
|
2.0
|
1.0
|
C30
|
E:6SS203
|
4.5
|
4.0
|
1.0
|
CB
|
E:ILE99
|
4.6
|
6.9
|
1.0
|
C35
|
E:6SS203
|
4.6
|
4.4
|
1.0
|
N15
|
E:6SS203
|
4.7
|
4.7
|
1.0
|
C32
|
E:6SS203
|
4.7
|
4.0
|
1.0
|
CG
|
E:HIS96
|
4.7
|
9.5
|
1.0
|
C
|
E:VAL93
|
4.8
|
6.7
|
1.0
|
N34
|
E:6SS203
|
4.8
|
4.2
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 5lay
Go back to
Fluorine Binding Sites List in 5lay
Fluorine binding site 6 out
of 6 in the Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Discovery of New Natural-Product-Inspired Spiro-Oxindole Compounds As Orally Active Inhibitors of the MDM2-P53 Interaction: HDM2 (MDM2) in Complex with Compound 6G within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
F:F201
b:12.7
occ:1.00
|
F38
|
F:6SS201
|
0.0
|
12.7
|
1.0
|
C37
|
F:6SS201
|
1.4
|
12.8
|
1.0
|
C2
|
F:6SS201
|
2.3
|
12.7
|
1.0
|
C6
|
F:6SS201
|
2.4
|
12.8
|
1.0
|
C7
|
F:6SS201
|
2.9
|
12.8
|
1.0
|
CL1
|
F:6SS201
|
2.9
|
12.4
|
1.0
|
C28
|
F:6SS201
|
2.9
|
12.7
|
1.0
|
C27
|
F:6SS201
|
3.2
|
12.7
|
1.0
|
C29
|
F:6SS201
|
3.5
|
12.5
|
1.0
|
C3
|
F:6SS201
|
3.6
|
12.6
|
1.0
|
C26
|
F:6SS201
|
3.6
|
12.8
|
1.0
|
C5
|
F:6SS201
|
3.7
|
12.7
|
1.0
|
CD1
|
F:ILE99
|
3.8
|
7.7
|
1.0
|
C33
|
F:6SS201
|
4.0
|
12.6
|
1.0
|
C4
|
F:6SS201
|
4.1
|
12.5
|
1.0
|
C30
|
F:6SS201
|
4.2
|
12.1
|
1.0
|
C9
|
F:6SS201
|
4.3
|
12.8
|
1.0
|
C32
|
F:6SS201
|
4.4
|
12.1
|
1.0
|
N11
|
F:6SS201
|
4.6
|
12.9
|
1.0
|
NE2
|
F:HIS96
|
4.6
|
8.7
|
1.0
|
C35
|
F:6SS201
|
4.6
|
13.1
|
1.0
|
N15
|
F:6SS201
|
4.6
|
12.6
|
1.0
|
N34
|
F:6SS201
|
4.7
|
13.0
|
1.0
|
CD2
|
F:HIS96
|
4.8
|
8.7
|
1.0
|
CE1
|
F:HIS96
|
4.8
|
8.6
|
1.0
|
CG2
|
F:ILE99
|
5.0
|
8.0
|
1.0
|
|
Reference:
A.Gollner,
D.Rudolph,
H.Arnhof,
M.Bauer,
S.M.Blake,
G.Boehmelt,
X.L.Cockroft,
G.Dahmann,
P.Ettmayer,
T.Gerstberger,
J.Karolyi-Oezguer,
D.Kessler,
C.Kofink,
J.Ramharter,
J.Rinnenthal,
A.Savchenko,
R.Schnitzer,
H.Weinstabl,
U.Weyer-Czernilofsky,
T.Wunberg,
D.B.Mcconnell.
Discovery of Novel Spiro[3H-Indole-3,2'-Pyrrolidin]-2(1H)-One Compounds As Chemically Stable and Orally Active Inhibitors of the MDM2-P53 Interaction. J. Med. Chem. V. 59 10147 2016.
ISSN: ISSN 1520-4804
PubMed: 27775892
DOI: 10.1021/ACS.JMEDCHEM.6B00900
Page generated: Thu Aug 1 11:20:05 2024
|